A derivative of platelet-derived growth factor receptor alpha binds to the trimer of human cytomegalovirus and inhibits entry into fibroblasts and endothelial cells

Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation

(2016) Giuseppe Gerna et al.   JOURNAL OF VIROLOGY

HCMV Induces Macropinocytosis for Host Cell Entry in Fibroblasts

(2016) Stefanie Hetzenecker et al.   TRAFFIC

gH/gL supercomplexes at early stages of herpesvirus entry

(2016) Ekaterina E Heldwein   Current Opinion in Virology

A permanently growing human endothelial cell line supports productive infection with human cytomegalovirus under conditional cell growth arrest

(2015) Diana Lieber et al.   BIOTECHNIQUES

Peptide therapeutics: current status and future directions

(2015) Keld Fosgerau et al.   DRUG DISCOVERY TODAY

Characterization of Cytomegalovirus Breakthrough Events in a Phase 2 Prophylaxis Trial of Letermovir (AIC246, MK 8228)

(2015) Peter Lischka et al.   JOURNAL OF INFECTIOUS DISEASES

Human Cytomegalovirus gH/gL/gO Promotes the Fusion Step of Entry into All Cell Types, whereas gH/gL/UL128-131 Broadens Virus Tropism through a Distinct Mechanism

(2015) Momei Zhou et al.   JOURNAL OF VIROLOGY

Perspective of Use of Antiviral Peptides against Influenza Virus

(2015) Sylvie Skalickova et al.   Viruses-Basel

Crystal Structure of the Human Cytomegalovirus Glycoprotein B

(2015) Heidi G. Burke et al.   PLoS Pathogens

Antigenic Characterization of the HCMV gH/gL/gO and Pentamer Cell Entry Complexes Reveals Binding Sites for Potently Neutralizing Human Antibodies

(2015) Claudio Ciferri et al.   PLoS Pathogens

Etanercept: A Review of Its Use in Autoimmune Inflammatory Diseases

(2014) Lesley J. Scott   DRUGS

Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes

(2014) Stephan Urban et al.   GASTROENTEROLOGY

Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies

(2014) Anna Kabanova et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Geno- and Phenotypic Characterization of Human Cytomegalovirus Mutants SelectedIn Vitroafter Letermovir (AIC246) Exposure

(2013) Thomas Goldner et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Entry inhibitors and their use in the treatment of HIV-1 infection

(2013) Aiman A. Haqqani et al.   ANTIVIRAL RESEARCH

Cytomegalovirus diseases after hematopoietic stem cell transplantation: A mini-review

(2013) Ella J. Ariza-Heredia et al.   CANCER LETTERS

Ganciclovir for the Treatment of Congenital Cytomegalovirus

(2013) Amanda Gwee et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Human Cytomegalovirus (HCMV) Glycoprotein gB Promotes Virus Entry In Trans Acting as the Viral Fusion Protein Rather than as a Receptor-Binding Protein

(2013) P. T. Wille et al.   mBio

Antibodies against the gH/gL/UL128/UL130/UL131 Complex Comprise the Majority of the Anti-Cytomegalovirus (Anti-CMV) Neutralizing Antibody Response in CMV Hyperimmune Globulin

(2012) A. E. Fouts et al.   JOURNAL OF VIROLOGY

Herpes Virus Fusion and Entry: A Story with Many Characters

(2012) Roselyn J. Eisenberg et al.   Viruses-Basel

PDGF Receptor-α Does Not Promote HCMV Entry into Epithelial and Endothelial Cells but Increased Quantities Stimulate Entry by an Abnormal Pathway

(2012) Adam L. Vanarsdall et al.   PLoS Pathogens

Fusing structure and function: a structural view of the herpesvirus entry machinery

(2011) Sarah A. Connolly et al.   NATURE REVIEWS MICROBIOLOGY

Cytomegalovirus Neutralization by Hyperimmune and Standard Intravenous Immunoglobulin Preparations

(2011) Christina B. Planitzer et al.   TRANSPLANTATION

Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection

(2011) Dai Wang et al.   VACCINE

Prevention of Cardiac Dysfunction in Acute Coxsackievirus B3 Cardiomyopathy by Inducible Expression of a Soluble Coxsackievirus-Adenovirus Receptor

(2009) Sandra Pinkert et al.   CIRCULATION

Synthetic therapeutic peptides: science and market

(2009) Patrick Vlieghe et al.   DRUG DISCOVERY TODAY

Isolation of Human Monoclonal Antibodies That Potently Neutralize Human Cytomegalovirus Infection by Targeting Different Epitopes on the gH/gL/UL128-131A Complex

(2009) A. Macagno et al.   JOURNAL OF VIROLOGY

A Human Cytomegalovirus gO-Null Mutant Fails To Incorporate gH/gL into the Virion Envelope and Is Unable To Enter Fibroblasts and Epithelial and Endothelial Cells

(2009) P. T. Wille et al.   JOURNAL OF VIROLOGY

Activation of EGFR on monocytes is required for human cytomegalovirus entry and mediates cellular motility

(2009) Gary Chan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Synthetic Gene Regulation Circuits for Control of Cell Expansion

(2009) Tobias May et al.   TISSUE ENGINEERING PART A

Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection

(2008) G. Gerna et al.   JOURNAL OF GENERAL VIROLOGY

Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E

(2008) C. Sinzger et al.   JOURNAL OF GENERAL VIROLOGY

Platelet-derived growth factor-α receptor activation is required for human cytomegalovirus infection

(2008) Liliana Soroceanu et al.   NATURE

Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection

(2008) Xiaohong Cui et al.   VACCINE